Samuel Mboggo

Samuel Mboggo is an accomplished regulatory affairs professional with extensive experience in leading global regulatory strategies for clinical trials. Currently serving as Associate Director of Regulatory Affairs at BridgeBio, Samuel manages regulatory submissions for ongoing Phase 2/3 clinical trials in multiple countries. Previously, Samuel held senior roles at Histogen, Conventus Biomedical Solutions, Atara Biotherapeutics, and Amgen, where expertise included developing regulatory strategies, authoring regulatory dossiers, and managing key regulatory interactions. Samuel is educated in regulatory affairs from the Regulatory Affairs Professionals Society and holds a Bachelor's Degree in Biotechnology from California State Polytechnic University-Pomona, alongside an Associate's Degree in Biochemistry and Molecular Biology from Irvine Valley College.